We are live on ! Find out more
PIM

Platinum Investment Management Portfolio holdings

AUM $397M
1-Year Est. Return 63.96%
This Fund
S&P 500
This Quarter Est. Return
+10.04%
1 Year Est. Return
+63.96%
3 Year Est. Return
+135%
5 Year Est. Return
+149.46%
10 Year Est. Return
+636.06%
AUM
$2.21B
AUM Growth
-$263M
Cap. Flow
-$363M
Cap. Flow %
-16.42%
Top 10 Hldgs %
64.67%
Holding
148
New
14
Increased
20
Reduced
67
Closed
26

Top Buys

Rank Stock Value
1
NICE icon
Nice
NICE
+$48.4M
2
PDD icon
Pinduoduo
PDD
+$27.7M
3
LW icon
Lamb Weston
LW
+$22.3M
4
BIRK icon
Birkenstock
BIRK
+$4.9M
5
AS icon
Amer Sports
AS
+$3.84M

Top Sells

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$101M
2
MU icon
Micron Technology
MU
+$72.7M
3
TCOM icon
Trip.com Group
TCOM
+$55.7M
4
MCHP icon
Microchip Technology
MCHP
+$51.5M
5
SWKS icon
Skyworks Solutions
SWKS
+$38M

Sector Composition

Rank Sector Weight
1 Financials 17.55%
2 Industrials 17.45%
3 Energy 14.94%
4 Consumer Discretionary 14.75%
5 Technology 14.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMZN icon
26
Amazon
AMZN
$2.96T
$12M 0.54%
64,315
+3,985
+7% +$727K
HTHT icon
27
Huazhu Hotels Group
HTHT
$13B
$10.6M 0.48%
286,153
– –
V icon
28
Visa
V
$677B
$9.73M 0.44%
35,405
+861
+2% +$233K
ZTS icon
29
Zoetis
ZTS
$30B
$7.82M 0.35%
40,000
– –
EXAI
30
DELISTED
Exscientia Plc American Depositary Shares
EXAI
$7.11M 0.32%
1,456,058
-476,146
-25% -$2.49M
CNTA
31
DELISTED
Centessa Pharmaceuticals
CNTA
$6.87M 0.31%
429,701
-66,194
-13% -$811K
APGE icon
32
Apogee Therapeutics
APGE
$10.2B
$6.33M 0.29%
107,694
-39,778
-27% -$1.91M
BCYC
33
Bicycle Therapeutics
BCYC
$292M
$6.16M 0.28%
272,149
-21,296
-7% -$491K
ROIV icon
34
Roivant Sciences
ROIV
$26.2B
$6.09M 0.28%
528,031
-41,714
-7% -$475K
VERA icon
35
Vera Therapeutics
VERA
$2.36B
$6.07M 0.27%
137,389
+973
+0.7% +$36.9K
JNJ icon
36
Johnson & Johnson
JNJ
$625B
$5.82M 0.26%
35,942
– –
IMVT icon
37
Immunovant
IMVT
$8.25B
$5.48M 0.25%
192,242
– –
AS icon
38
Amer Sports
AS
$21.4B
$4.79M 0.22%
+300,000
New +$3.84M
AAPL icon
39
Apple
AAPL
$4.57T
$4.66M 0.21%
20,000
-14,133
-41% -$3.16M
IDYA icon
40
IDEAYA Biosciences
IDYA
$3.56B
$4.58M 0.21%
144,717
– –
ADCT icon
41
ADC Therapeutics
ADCT
$144M
$4.55M 0.21%
1,444,516
+148,363
+11% +$468K
BIRK icon
42
Birkenstock
BIRK
$7.07B
$4.44M 0.2%
+90,000
New +$4.9M
BKNG icon
43
Booking.com
BKNG
$161B
$4.21M 0.19%
25,000
-4,625
-16% -$709K
ZYME icon
44
Zymeworks
ZYME
$1.67B
$4.11M 0.19%
327,522
-45,480
-12% -$495K
MBX
45
MBX Biosciences
MBX
$3.27B
$3.9M 0.18%
+150,000
New +$3.43M
MSFT icon
46
Microsoft
MSFT
$3.71T
$3.87M 0.18%
8,989
+400
+5% +$171K
WVE icon
47
Wave Life Sciences
WVE
$1.2B
$3.79M 0.17%
461,667
-75,678
-14% -$452K
CSGP icon
48
CoStar Group
CSGP
$12.3B
$3.77M 0.17%
50,000
– –
ACIU icon
49
AC Immune
ACIU
$240M
$3.6M 0.16%
952,069
– –
QTRX icon
50
Quanterix
QTRX
$190M
$3.6M 0.16%
277,636
– –
1
2
3 4 5

Similar funds

LCG
Lisanti Capital Growth New York $397M AUM 178.66% 1-Year Est. Return
EH
EMG Holdings Old Greenwich, Connecticut $397M AUM 9.97% 1-Year Est. Return
TPWA
Twin Peaks Wealth Advisors Burlingame, California $397M AUM 23.23% 1-Year Est. Return
VC
Vision Capital Toronto, Ontario, Canada $397M AUM 0.8% 1-Year Est. Return
IVLAV
Index Venture Life Associates VI St. Helier, Jersey $396M AUM 176.22% 1-Year Est. Return
GPC
Greenstone Partners & Co Larkspur, California $395M AUM 35.56% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return

Platinum Investment Management's Q3 2024 Portfolio in Review

As of Q3 2024, Platinum Investment Management held 148 positions worth $2.21B, down 11% from $2.47B the previous quarter. Its ten largest holdings account for 65% of the portfolio.

Platinum Investment Management withdrew a net $363M in Q3 2024, closing 26 positions and reducing 67 holdings. Its most notable exit was Moderna, an estimated $2.16M position sold in full.

By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 12% a quarter earlier, followed by Industrials and Energy.

Against the trend, Platinum Investment Management opened a new position in Birkenstock worth $4.44M.

  • Platinum Investment Management's largest Q3 2024 buy was Birkenstock: 90,000 shares worth $4.44M.
  • Platinum Investment Management added most to Nice in Q3 2024, an estimated $48.4M increase.
  • Platinum Investment Management's biggest Q3 2024 reduction was Broadcom, cutting an estimated $101M.
  • Platinum Investment Management fully exited Moderna in Q3 2024, selling an estimated $2.16M.
  • Platinum Investment Management's ten largest holdings make up 65% of its $2.21B portfolio in Q3 2024.
  • Platinum Investment Management opened 14 new positions and closed 26 in Q3 2024.
  • Platinum Investment Management's portfolio value fell 11% quarter-over-quarter to $2.21B.

Based on Platinum Investment Management's 13F filing for Q3 2024, filed 8 Nov 2024.